4Caixia T, Hongwen F, Xiran L. Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo. J Dermatol Sci, 1999,21 (1):59.
5Yu HS, Chang KL, Yu CL, et al. Alterations in IL-6,IL-8, GM- CSF, TNF-alpha and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo. J Invest Dermatol , 1997, 108(4): 527.
6Swope VB, Malek ZA, Kassem LM, et al. Interleukins 1 a and 6 and tumor necrosis factor a are paracrine inhibitors of human melanocyte proliferation and mela nogeneis. J Invest Dermatol, 1991,96(2): 180.
7Kimbauer R, Charvat B, Schauter K, et al. Modulation of intercelluar adhesion molecule-1 expression on human melanocytes and melanoma cells: evidence for aregulatory role of IL-5, IL-7,TNF-a and UVB light.J Invest Dermatol, 1992,98(3): 320.
8Bernstein D, Reddy KR, Jeffers L, et al. Canities and vitiligo complicating interferon therapy for hepatitis C.Am J Gastroenterol, 1995,90(7): 1176.
9Hwang JH, Ahn JS, Kim SD, et al. The changes of serum soluble intercellular adhesion molecule-1 after steroid treatment in vitiligo. J Dermatol Sci, 1999, 22(1): 11.
10Mozzanica N, Villa ML, Foppa S, et al. Plasma alphamelanocyte-stimulating hormone, beta-endorphin and natural killer cell activity in vitiligo. J Am Acad Dermatol, 1992, 26(5 pt 1): 693.
8Grines PE. New insights and new therapies in vitiligo [ J ]. JAMA ,2005,239 (6) :730 - 735.
9Wu CS, Yu CL, Wu CS, et al. Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes [ J ]. Exp Dermatol ,2004,13 ( 12 ) :755 - 763.
10Wu CS,Lan CC,Wang LF,et al. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo [ J ]. Br J Dermatol, 2007,156( 1 ) : 122 - 129.
